These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22233646)

  • 21. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of Titration-Based Screening for the Rapid Pilot Testing of High-Throughput Assays.
    Zhang JH; Kang ZB; Ardayfio O; Ho PI; Smith T; Wallace I; Bowes S; Hill WA; Auld DS
    J Biomol Screen; 2014 Jun; 19(5):651-60. PubMed ID: 24246376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HTS promiscuity analyses for accelerating decision making.
    Böcker A; Bonneau PR; Edwards PJ
    J Biomol Screen; 2011 Aug; 16(7):765-74. PubMed ID: 21680863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which aspects of HTS are empirically correlated with downstream success?
    Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
    Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profile-QSAR: a novel meta-QSAR method that combines activities across the kinase family to accurately predict affinity, selectivity, and cellular activity.
    Martin E; Mukherjee P; Sullivan D; Jansen J
    J Chem Inf Model; 2011 Aug; 51(8):1942-56. PubMed ID: 21667971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput screening of a small molecule library for promoters and inhibitors of mesenchymal stem cell osteogenic differentiation.
    Brey DM; Motlekar NA; Diamond SL; Mauck RL; Garino JP; Burdick JA
    Biotechnol Bioeng; 2011 Jan; 108(1):163-74. PubMed ID: 20824673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancements of screening collections to address areas of unmet medical need: an industry perspective.
    Drewry DH; Macarron R
    Curr Opin Chem Biol; 2010 Jun; 14(3):289-98. PubMed ID: 20413343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statistical analysis of systematic errors in high-throughput screening.
    Kevorkov D; Makarenkov V
    J Biomol Screen; 2005 Sep; 10(6):557-67. PubMed ID: 16103415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality control methodology for high-throughput protein-protein interaction screening.
    Vazquez A; Rual JF; Venkatesan K
    Methods Mol Biol; 2011; 781():279-94. PubMed ID: 21877286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual screening strategies in drug discovery.
    McInnes C
    Curr Opin Chem Biol; 2007 Oct; 11(5):494-502. PubMed ID: 17936059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An effective method for controlling false discovery and false nondiscovery rates in genome-scale RNAi screens.
    Zhang XD
    J Biomol Screen; 2010 Oct; 15(9):1116-22. PubMed ID: 20855561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A natural products approach to drug discovery: probing modes of action of antitumor agents by genome-scale cDNA library screening.
    Luesch H; Abreu P
    Methods Mol Biol; 2009; 572():261-77. PubMed ID: 20694698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of strictly standardized mean difference for hit selection in primary RNA interference high-throughput screening experiments.
    Zhang XD; Ferrer M; Espeseth AS; Marine SD; Stec EM; Crackower MA; Holder DJ; Heyse JF; Strulovici B
    J Biomol Screen; 2007 Jun; 12(4):497-509. PubMed ID: 17435171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The developing zebrafish (Danio rerio): a vertebrate model for high-throughput screening of chemical libraries.
    Lessman CA
    Birth Defects Res C Embryo Today; 2011 Sep; 93(3):268-80. PubMed ID: 21932435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTS-Corrector: software for the statistical analysis and correction of experimental high-throughput screening data.
    Makarenkov V; Kevorkov D; Zentilli P; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2006 Jun; 22(11):1408-9. PubMed ID: 16595559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.